Skip to main content

Table 1 Patient characteristics

From: Local control and recurrence patterns after stereotactic irradiation delivered in more than 4 fractions for hepatocellular carcinomas and liver metastases: a retrospective study

Characteristics

n = 33

Age (years), median [IQR]

68 [61—79]

Sex

Male

Female

21 (64)

12 (36)

ECOG performance status

0–1

2

32 (97)

1 (3)

Liver cirrhosis (Child Pugh classification)

A5-A6

B7

No cirrhosis

11 (33)

1 (3)

21 (64)

Tumour histology

HCC

Colorectal metastasis

Other histology metastasis

13 (39)

8 (24)

12 (37)

Vascular or biliary invasion

No

33 (100)

Previous liver local therapy

No treatment

Any treatment

Surgery

TACE

RFA

SBRT

Conventional RT

13 (39)

20 (61)

12 (60)

6 (30)

4 (20)

5 (25)

2 (10)

Extrahepatic disease at SBRT

None

1 to 4 lesions

 > 4 lesions

31 (94)

2 (6)

0 (0)

Time from initial disease diagnosis to target lesion diagnosis (months), median [IQR]

29 [7—37]

  1. Results presented as n (%) unless otherwise specified. ECOG (Eastern cooperative oncology group); HCC (Hepatocellular carcinoma); TACE (Transarterial chemoembolization); RFA (Radiofrequency ablation); SBRT (Stereotactic body radiotherapy); RT (Radiotherapy); IQR (Interquartile Range)